← FDA Drug Approvals (Drugs@FDA)
SUMATRIPTAN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2021-02-17
Drug application
- FDA Application #
ANDA208967- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SUMATRIPTAN
- Generic name
- SUMATRIPTAN
- Active ingredients
- SUMATRIPTAN
- Dosage form
- SPRAY
- Route
- NASAL
- Marketing status
- Prescription
- Sponsor
- REGCON HOLDINGS
- Manufacturer
- Florida Pharmaceutical Products, LLC.
- First approval
- 2021-02-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown